enVVeno Medical (NVNO) Return on Capital Employed (2018 - 2026)
enVVeno Medical (NVNO) posted quarterly Return on Capital Employed of 74.49% for Q2 2026, down 455.0% year-over-year from 20.98% in Q2 2025, and up 4.36% quarter-over-quarter from 77.89% in Q1 2026.
enVVeno Medical (NVNO) Return on Capital Employed (2018 - 2026) Analysis & Trends
enVVeno Medical's Return on Capital Employed history runs 9 years deep, the most recent figure standing at 74.49% for Q2 2026.
- In Q2 2026, Return on Capital Employed fell 455.0% year-over-year to 74.49%; the TTM figure through Jun 2026 stood at 74.49% (down 455.0% YoY), while the FY2025 annual figure was 59.48%, down 618.0% from the prior year.
- Return on Capital Employed for Q2 2026 stood at 74.49%, up from 77.89% in the prior quarter.
- The five-year high for Return on Capital Employed was 35.51% in Q1 2022, with the low at 90.59% in Q3 2023.
- The 5-year median for Return on Capital Employed is 63.77% (2022), against an average of 63.9%.
- The sharpest annual moves came in 2022 and 2024: Return on Capital Employed plunged 3491 bps in 2022, then surged 3675 bps in 2024.
- enVVeno Medical's Return on Capital Employed stood at 59.32% in 2022, then slipped by 15 bps to 68.22% in 2023, then rose by 23 bps to 52.28% in 2024, then sank by 39 bps to 72.48% in 2025, then declined by 3 bps to 74.49% in 2026.
- Business Quant data shows NVNO's Return on Capital Employed at 74.49% in Q2 2026, 77.89% in Q1 2026, and 72.48% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 12.08% |
| 10 | enVVeno Medical | 7.05 Mn | 7.05 Mn | - | -74.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -74.49% |
| Mar 31, 2026 | -77.89% |
| Dec 31, 2025 | -72.48% |
| Sep 30, 2025 | -73.55% |
| Jun 30, 2025 | -69.94% |
| Mar 31, 2025 | -56.63% |
| Dec 31, 2024 | -52.28% |
| Sep 30, 2024 | -53.85% |
| Jun 30, 2024 | -54.79% |
| Mar 31, 2024 | -52.92% |
| Dec 31, 2023 | -68.22% |
| Sep 30, 2023 | -90.59% |
| Jun 30, 2023 | -81.23% |
| Mar 31, 2023 | -69.51% |
| Dec 31, 2022 | -59.32% |
| Sep 30, 2022 | -59.20% |
| Jun 30, 2022 | -47.79% |
| Mar 31, 2022 | -35.51% |
| Dec 31, 2021 | -29.71% |
| Sep 30, 2021 | -24.29% |